Europe must continue to lead on harm reduction (Harm Reduction Journal, October 2, 2024)
Psychedelic research at a crossroads (Science, October 2, 2024)
Prevention, treatment and care of substance use disorders among adolescents (World Psychiatry, October 2, 2024)
Buprenorphine discontinuation in telehealth-only treatment for opioid use disorder: A longitudinal cohort analysis (Journal of Substance Use and Addiction Treatment, October 2, 2024)
BRAIN at 10: A View from the National Institute on Drug Abuse (NIDA Director's blog, October 2, 2024)
Disparities in Medication Use for Criminal Justice System–Referred Opioid Use Disorder Treatment (Free pdf down
Attitudes toward driving after cannabis use: a systematic review (Journal of Cannabis Research, September 30, 2024)
Real world clinical outcomes of treatment of cannabis-induced psychosis and prevalence of cannabis-related primary psychosis: a retrospective study (BMC Psychiatry, September 30, 2024)
Exploring the progression of drug dependence in a methamphetamine self-administration rat model through targeted and non-targeted metabolomics analyses (Nature, September 30, 2024)
Cannabis cue-reactivity in cannabis use disorder: Diverging evidence in two distinct cannabis cultures (Journal of
Cocaine-induced destruction of the palate: a diagnostic and management challenge (British Dental Journal, September 27, 2024)
Telemedicine for Initiation of Alcohol Use Disorder Medications (JAMA Network Open, September 25, 2024)
Discussing the concept of substance-induced psychosis (Psychological Medicine, September 25, 2024)
Health Warnings on Instagram Advertisements for Synthetic Nicotine E-Cigarettes and Engagement (Free pdf download, JAMA Open Network, September 25, 2024)
High times and troubled relationships: Recreational marijuana laws and intimate partner violence (Economics and Human Biology, September 20, 2024)
Cannabis Laws and Utilization of Medications for the Treatment of Mental Health Disorders (Free pdf, JAMA Network Open, September 18, 2024)
Age-friendly care for older adults with substance use disorder (The Lancet, September 17, 2024)
Onset and exacerbation of first episode psychosis associated with cannabis withdrawal: A case series (Psychiatry Research Case Reports, September 15, 2024)
Why People Use Cannabis and Why It Matters: A Narrative Review (Current Addiction Reports, September 15, 20
Twenty-Year Trends in Drug Overdose Fatalities Among Older Adults in the US (JAMA Psychiatry, September 15, 2024. Free pdf download)
Household Compositions and Substance Use among Young Adults in the U.S. (International Journal of Environmental Research and Public Health, September 11, 2024)
Interventions to reduce harms related to drug use among people who experience incarceration: systematic review and meta-analysis (The Lancet, September 11, 2024)
Systematic Review on Mortality in the Elderly on Methadone Maintenance Treatment (Cureus, September 8, 2024)
A systematic review of deep brain stimulation for substance use disorders (Translational Psychiatry, September 6, 2024)
Integrated telehealth intervention to reduce chronic pain and unhealthy drinking among people living with HIV: protocol for a randomized controlled trial (Addiction Science and Clinical Practice, September 6, 2024)
Implementation of a rural emergency department-initiated buprenorphine program in the mountain west: a study protocol (Addiction Science and Clinical Practice, September 3, 2024)
Preventing Substance Use Among Young Adults with Disabilities (SAMHSA, September 2, 2024)
Pharmacological Treatments for Methamphetamine Use Disorder: Current Status and Future Targets (Substance Use Rehabilitation, August 30, 2024)
2023 National Survey on Drug Use and Health Annual National Report (SAMHSA, August 30, 2024)
DOSE Dashboard: Nonfatal Overdose Syndromic Surveillance Data (CDC, August 30, 2024)
Ketamine-assisted buprenorphine initiation: a pilot case series (Addiction Science and Clinical Practice, August 30, 2024)
Harm Reduction and Treatment Among People at High Risk of Overdose (JAMA Network Open, August 28, 2024. Free pdf download)
ASAM Guest Editorial: Physicians not widely adopting evidence-based practices to help reduce addiction morbidity and mortality (American Society of Addiction Medicine, August 16, 2024)
Investigation of Illnesses: Diamond Shruumz-Brand Chocolate Bars, Cones, & Gummies (FDA, August 16, 2024)
Cannabis use disorder and substance use treatment among U.S. adults (Journal of Substance Use and Addiction Treatment, August 16, 2024)
The associations of supervised consumption services with the rates of opioid-related mortality and morbidity outcomes at the public health unit level in Ontario (Canada): A controlled interrupted time-series analysis (Drug and Alcohol Review, August 15, 2024)
Mapping Psilocybin’s Brain Effects to Explore Potential for Treating Mental Health Disorders (NIH Director's blog, August 15, 2024)
Benzodiazepine use in relation to long-term dementia risk and imaging markers of neurodegeneration: a population-based study (BMC Medicine, August 14, 2024)
Death Due to Caffeine and Methamphetamine Toxicity: A Case Report (Cureus, August 12, 2024)
Cannabis and head and neck cancer, (JAMA Otolaryngology, Head and Neck Cancer, August 11, 2024)
Research decodes how cocaine alters dopamine transporter function (Frontiers in Public Health, August 7, 2024)
Non-improvement predicts subsequent non-response to repeated-dose intravenous ketamine for depression: a re-analysis of a 2-week open-label study in patients with unipolar and bipolar depression (Translational Psychiatry, August 6, 2024)
Psychedelics and the ‘inner healer’: Myth or mechanism? (Journal of Psychopharmacology, August 4, 2024)
Exploring perceptions of genetic risk and the transmission of substance use disorders (Addiction Science and Clinical Practice, August 3, 2024)
Reducing Barriers to Behavioral Health and Substance Use Disorder Treatment (American Hospital Association, August 1, 2024)
Atrial Fibrillation Following Cannabis Use: A Case Report Highlighting the Potential Cardiovascular Effects (Journal of Resuscitation, July 28, 2024)
Psilocybin desynchronizes the human brain (Nature, July 25, 2024)
Secondhand Nicotine Absorption from E-Cigarette Vapor vs Tobacco Smoke in Children (JAMA Open Network, July 24, 2024. Free pdf download)
Cannabinoids as alleviating treatment for core symptoms of autism spectrum disorder in children and adolescents (Nordic Journal of Psychiatry, July 24, 2024)
ASAM’s Comments in Response to the Proposed Rule on Schedules of Controlled Substances: Rescheduling of Marijuana (American Society of Addiction Medicine, July 23, 2024)
ASAM Weekly Guest Editorial: To Address the Fentanyl Crisis, Greater Access to Methadone Is Needed (NIDA Director Nora Volkow, MD)
Prenatal Cannabis Use and Maternal Pregnancy Outcomes (JAMA Internal Medicine, July 22, 2024. Free pdf download without registration)
From Chronic Cannabis to Cyclic Chaos: A Glimpse into Cannabinoid Hyperemesis Syndrome (Cureus, July 21, 2024)
The anxiolytic effects of cannabinoids: A comprehensive review (Pharmacology, Biochemistry and Behavior, July 20, 2024)
Physician Reluctance to Intervene in Addiction (JAMA Open Network, July 17, 2024. Free pdf)
AMA Overdose Epidemic Report: 2023 (AMA, July 13, 2024)
Reported Xylazine Use Among Adults Aged ≥18 Years (CDC, July 10),
Perspectives of researchers with lived experience in implementation science research: Opportunities to close the research-to-practice gap in substance use systems of care (Sage Journals, July 10, 2024)
The Role of Different Types of Cannabinoids in Periodontal Disease: An Integrative Review (Pharmaceutics, July 7, 2028)
Disrupted Access to Prescription Stimulant Medications Could Increase Risk of Injury and Overdose (CDC, July 6, 2024)
Benzodiazepine use in relation to long-term dementia risk and imaging markers of neurodegeneration (BMC Medicine, July 2, 2024)
Burden of drug use disorders in the United States from 1990 to 2021 and its projection until 2035 (BMC Public Health, July 2, 2024)
Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial (Nature Medicine, July 1, 2024)
Knowledge, Attitudes, and Beliefs About Opioid Use Disorder Treatment in Primary Care (JAMA Network Open, June 30, 2024. Free pdf download)
Harm reduction strategies for cannabis-related problems: a literature review and typology (European Journal of Psychiatry and Clinical Neuroscience, June 30, 2024)
More Gaps in the Cascade of Care for Opioid Use Disorder (JAMA Network, June 27, 2024)
Methamphetamine Plan Implementation Report (Office of National Drug Control Policy, June 21, 2024)
Illnesses Related to Diamond Shruumz-Brand Chocolate Bars, Cones, & Gummies (CDC, June 21, 2024)
Activity relationships and forensic case series of emerging 2-benzylbenzimidazole ‘nitazene’ opioids (Archives of Toxicology, June 21, 2024)
Widespread reductions in cortical thickness following ketamine abuse (Journal of Psychiatry and Neuroscience, June 13, 2024)
Randomized Placebo-Controlled Clinical Trial of Dutasteride for Reducing Heavy Drinking in Men (Journal of Clinical Psychopharmacology, June 10, 2024)
A meta-analysis of the effects of ketamine on suicidal ideation in depression patients (Translational Psychiatry, June 10, 2024)
Edible cannabis legalization and cannabis poisonings in older adults (Free pdf download JAMA Internal Medicine, June 7, 2024)
Sudden cardiac arrest occurring in temporal proximity to consumption of energy drinks (Heart Rhythm, June 7, 2024)
Factors associated with the use of benzodiazepine and opioid prescription drug in the student population: a cross-sectional study (Nature, June 6, 2024)
The Developmental Trajectory to Cannabis Use Disorder (American Journal of Psychiatry, June 6, 2024)
Alcohol Use Disorder and Dementia: A Review (Alcohol Research: Current Reviews, June 6, 2024)
2F-2OXO-PCE — A new synthetic hallucinogen identified in drug markets across North America (Center for Forensic Research and Education, May 30, 2024)
Editorial: Individual differences in addictive behaviors (Frontiers in Psychology, May 30, 2024)
Commentary: Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report (Frontiers in Psychiatry, May 30, 2024)
NIAAA releases strategic plan: 2024-2028 (NIAAA, May 29, 2024)
Read the NIAAA Director's message here
At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data (Journal of Affective Disorders, May 29, 2024)
Short-Acting, Full Agonist Opioids During Initiation of Opioid Agonist Treatment in the Fentanyl Era (JAMA Network Open, May 29, 2024)
Long-term follow-up of participants in ketamine clinical trials for mood disorders (Journal of Affective Disorders, May 29, 2024)
Longitudinal trajectories in recovery capital and associations with substance use among adult drug treatment court clients (Drug and Alcohol Dependence, May 29, 2024)
Efficacy of ketamine versus esketamine in the treatment of perioperative depression: A review (Pharmacology, Biochemistry and Behavior, May 27, 2024)
Evaluation of the Association Between Prenatal Cannabis Use and Risk of Developmental Delay (JAACAP Open, May 26, 2024)
The influence of adverse childhood experiences and depression on addiction severity among methamphetamine users: exploring the role of perseveration (Frontiers in Psychiatry, May 23, 2024)
Effects of exercise interventions on negative emotions, cognitive performance and drug craving in methamphetamine addiction (Frontiers in Psychiatry, May 23, 2024)
Comprehensive vaping bans are associated with lower odds of initiation into electronic nicotine delivery systems use among young people (Addiction, May 22, 2024)
Prevalence of high impulsivity and its relation to sleep indices in opioid use disorder patients receiving methadone maintenance treatment (Journal of Psychiatric Research, May 21, 2024)
Harm Reduction: Findings from the Field (SAMHSA, May 18, 2024)
Barriers to Buprenorphine Dispensing by Medicaid-Participating Community Retail Pharmacies (Free pdf download, JAMA, May 18, 2024)
Model compounds for evaluating the reactivity of amphetamine-type stimulants (Forensic Science International, May 18, 2024)
Xylazine is an agonist at kappa opioid receptors and exhibits sex-specific responses to opioid antagonism (Addiction Neuroscience, May 17, 2024)
Developing practical strategies to reduce addiction-related stigma and discrimination in public addiction treatment centers: a mixed-methods study protocol (Addiction Science and Clinical Practice, May 17, 2023)
12 Month-ending Provisional Number and Percent Change of Drug Overdose Deaths (CDC, May 15, 2024)
U.S. DEA releases National Drug Threat Assessment 2024. (DEA, May 9, 2024)
Hallucinogens: Large Increases in Use Since 2015 (Carnevale Associates, May 8, 2024)
The screening of cannabis addiction using machine learning, MoCA, and anxiety/depression tests (Scientific African, May 5, 2024)
An acute phase reaction from zoledronate mimicking symptoms seen in opioid withdrawal: a case report (Addiction Science and Clinical Practice, May 2, 2024)
Editorial: Confronting Addiction from Prevention to Recovery (ASAM, April 30, 2024)
ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (ASAM, April 30, 2024)
Hospital admissions among patients with Comorbid Substance Use disorders: a secondary analysis of predictors from the NavSTAR Trial (Addiction Science and Clinical Practice, April 29, 2024)
Associations of cannabis use, use frequency, and cannabis use disorder with violent behavior among young adults in the United States (International Journal of Drug Policy, August 28, 2024)
Chronic Cannabis Use in Everyday Life: Emotional, Motivational, and Self-Regulatory Effects of Frequently Getting High (Social Psychological Personality Science, April 27, 2024)
Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality (Journal of Addiction Medicine, April 26, 2024)
Withdrawal during outpatient low dose buprenorphine initiation in people who use fentanyl: a retrospective cohort study (Harm Reduction Journal, April 26, 2024)
Overdose from Unintentional Fentanyl Use when Intending to Use a Non-opioid Substance (Journal of Urban Health, April 26, 2024)
Personality changes related to presence and treatment of substance use (disorders): a systematic review (Psychological Medicine, April 24, 2024)
Perinatal substance use disorder: examining the impact on adverse pregnancy outcomes (European Journal of Obstetrics and Gynecology, April 23, 2024)
Opioid Overdose Knowledge Among Adolescents and Young Adults (Free pdf download, JAMA Pediatrics, April 22, 2024)
Digital Interventions for Recreational Cannabis Use Among Young Adults (JMIR Publications, April 21, 2024)
Perioperative Cannabinoids Significantly Reduce Postoperative Opioid Requirements in Patients Undergoing Coronary Artery Bypass Graft Surgery ( Cureus, April 20, 2024)
Alprazolam exposure during adolescence induces long-lasting dysregulation in reward sensitivity to morphine and second messenger signaling in the VTA-NAc pathway (Nature Scientific Reports, April 19, 2024)
Online surveillance of novel psychoactive substances (NPS): Monitoring Reddit discussions as a predictor of increased NPS-related exposures (Intenational Journal of Drug Policy, April 19, 2024)
NDEWS Report: Insights into pentobarbital (NIDA, April 19, 2024)
Ketamine induces multiple individually distinct whole-brain functional connectivity signatures (eLifeScience, April 17, 2024)
Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial (Nature Scientific Reports, April 17, 2024)
High frequency deep brain stimulation of the dorsal raphe nucleus prevents methamphetamine priming-induced reinstatement of drug seeking in rats (Translational Psychiatry, April 16, 2024)
Understanding the patient and supporter journey in cocaine use disorder (Frontiers in Psychiatry, April 16, 2024)
Attitudes of Black American Christian church leaders toward opioid use disorder, overdoses, and harm reduction: a qualitative study (Frontiers in Psychiatry, April 11, 2024)
Evidence-based whole person care for pregnant people who have opioid use disorder (SAMHSA, April 9, 2024)
Healthcare staff’s perspectives on long-acting injectable buprenorphine treatment: a qualitative interview study (Addiction Science and Clinical Practice, April 6, 2024)
The Management of Xylazine Overdose With Naloxone (Cureus, April 5, 2024)
Increased sensitivity for negative emotional images in individuals with problematic pornography use (Frontiers in Psychology, April 5, 2024)
Neuromodulation for Cannabis Use: A Scoping Review (Brain Sciences, April 5, 2024)
The clinical use of cannabinoids for pain (World Journal of Advanced Research and Reviews, April 3, 2024)
Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases (JAMA Psychiatry, March 28, 2024)
Serial mediating effects of childhood trauma and conduct behaviors on the impact of family history among patients with alcohol use disorder (Nature Scientific Reports, March 27, 2024)
Efficacy of intravenous racemic ketamine and intranasal esketamine with dose escalation for treatment-resistant depression: A systematic review and meta-analysis (Journal of Affective Disorders, March 27, 2024)
Psilocybin enhances insightfulness in meditation (Nature Scientific Reports, March 27, 2024)
Treatment seeking for gambling disorder in nationwide register data (Frontiers in Public Health, March 26, 2024)
Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids (Frontiers in Public Health, March 26, 2024)
Recovery-supportive interventions for people with substance use disorders: a scoping review (Frontiers in Psychiatry, March 26, 2024)
Alcohol-related ED visits (SAMHSA, March 23, 2024)
AMA Overdose Epidemic Report 2023 (JAMA, March 23, 2024)
Providers perceptions of systems-level barriers and facilitators to utilizing family-based treatment approaches in adolescent and young adult opioid use disorder treatment (Addiction Science and Clinical Practice, March 21, 2024)
Co-occurrence of mental illness and substance use among US pregnant individuals, 2012-2021 (Psychiatric Research, March 20, 2024)
Terpenoid Synergy: UnPsychiatric veiling the Therapeutic Mosaic in the Treatment of Cannabinoid Addiction (Drug, Addiction and Therapeutics, March 18, 2024)
Sleep-Related Predictors of Risk for Alcohol Use and Related Problems in Adolescents and Young Adults (Alcohol Research: Current Reviews, March 18, 2024)
Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study (Nature, March 15, 2024)
White House Challenge to Save Lives from Overdose (White House, March 13, 2024)
Association of Cannabis Use With Cardiovascular Outcomes Among US Adults (Journal of the American Heart Association, March 12, 2024)
Cannabis donation as a harm reduction strategy: a case study (Harm Reduction Journal, March 12, 2024)
Histories of violence among clients seeking substance use disorder treatment: a systematic mapping review (Frontiers in Psychiatry, March 12, 2024)
Clinical Practice Update on Diagnosis and Management of Cannabinoid Hyperemesis Syndrome: Commentary (Gastroenterology, March 8, 2024)
A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol (BMC Psychiatry, March 8, 2024)
Cannabis use and the prevalence of current asthma among adolescents and adults in the United States (Preventative Medicine, March 8, 2024)
Problematic pornography use across countries, genders, and sexual orientations: Insights from the International Sex Survey and comparison of different assessment tools (Addiction, March 8, 2024)
The association between marijuana and e-cigarette use and exercise behavior among adults (Preventative Medicine Reports, March 8, 2024)
The Rapidly Shifting Ketamine Landscape in the US (JAMA Open Network, March 7, 2024)
Clinical efficacy of adjunctive esketamine anesthesia in electroconvulsive therapy for major depressive disorders: A pragmatic, randomized, controlled trial (Psychiatric Research, March 7, 2024)
Methylphenidate (Ritalin) and Short-Term Cardiovascular Risk (Free pdf download, JAMA Open Network, March 6, 2024)
The dopamine 3 receptor as a candidate biomarker and therapeutic for opioid use disorder (Addiction Biology, March 6, 2024)
Deaths from Excessive Alcohol Use — United States, 2016–2021 (CDC, March 5, 2024)
Patient perspectives on current and potential therapies and clinical trial approaches for cocaine use disorder (Frontiers in Psychiatry, March 5, 2024)
Cardiotoxicity After Synthetic Cathinone Use (Cardiovascular Toxicity, February 29, 2024)
Integrating substance use peer support and screening brief intervention and referral to treatment services in the emergency department: a descriptive study of the ED leads program (Addiction Science and Clinical Practice, February 29, 2024)
Cannabidiol, cognition and schizophrenia: a narrative review (Exploration of Medicine, February 28, 2024)
Federal Policy Changes Must Occur to Provide a Lifesaving Stimulant Drug Intervention (Health Affairs Forefront, February 27, 2024)
Cannabis and Anxiety: A Critical Review (Medical Cannabis and Cannabinoids, February 26, 2024)
Predictors of response to intranasal ketamine in patients hospitalized for treatment-resistant depression (Personalized Medicine in Psychiatry, February 25, 2024)
FDA warns patients and health care providers about potential risks associated with compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders (FDA, February 23, 2024)
Incorporating harm reduction into alcohol use disorder treatment and recovery (National Institute on Alcohol and Alcohol Abuse/NIAAA, February 21, 2024)
Cannabis Consumption and the Emergence of Giant Lung Bullae: A Case Report and Clinical Analysis (HCA, February 18, 2024)
Forensic implications of novel synthesis of cathinone derivatives (Forensic Chemistry, February 18, 2024)
Routes of Drug Use Among Drug Overdose Deaths — United States, 2020–2022 (CDC, February 15, 2024)
Diffusion of medications for opioid use disorder treatment in jail settings: a convergent mixed methods study of jail staff perspectives (Addiction Science and Clinical Practice, February 14, 2024)
Fact Sheet 42 CFR Part 2 Final Rule (SAMHSA, February 8, 2024)
Opioid use disorder: current trends and potential treatments (Frontiers in Public Health, February 8, 2024)
Proposed Framework for The ASAM Criteria, Fourth Edition: Correctional Settings & Community Reentry (ASAM, February 6, 2024)
Toward a Harm Reduction Approach to Cannabis Use Disorder (American Journal of Psychiatry, February 6, 2024)
Structural indices of brain aging in methamphetamine use disorder (Drug and Alcohol Dependence, February 6, 2024)
Polysubstance mortality trends in White and Black Americans during the opioid epidemic, 1999–2018 (BMC Public Health, February 6, 2024)
A brief measure of non-drug reinforcement: Association with treatment outcomes during initial substance use recovery (Drug and Alcohol Dependence, February 2, 2024)
White House Drug Policy Director Statement on New Actions to Expand Access to Treatment and Save Lives (Office of National Drug Control Policy, February 2, 2024)
US trends in the association of suicide ideation/behaviors with marijuana use among adolescents ages 12–17 and differences by gender and race/ethnicity (Frontiers in Psychiatry, February 2, 2024)
Lisdexamfetamine-Induced Psychosis in a Patient With Neurodevelopmental Disorder (Cureus, February 2, 2024)
Justice Department Secures Agreement with Pennsylvania Courts to Resolve Lawsuit Concerning Discrimination Against People with Opioid Use Disorder (U.S. Department of Justice, February 2, 2024)
Cannabis Use and Car Crashes: A Review (Frontiers in Psychiatry, February 1, 2024)
Proceedings of the 19th annual conference of INEBRIA (Addiction Science and Clinical Practice, January 31, 2024)
Genetics of gambling disorder and related phenotypes: The potential uses of polygenic and multifactorial risk models to enable early detection and improve clinical outcomes (Journal of Behavioral Addictions, January 26, 2024)
Consumer Guide: How Can a Peer Specialist Support My Recovery From Problematic Substance Use? (SAMHSA, January 25, 2024)
A brief measure of non-drug reinforcement: Association with treatment outcomes during initial substance use recovery (Addiction, January 25, 2024)
The cycle of solitude and avoidance: a daily life evaluation of the relationship between internet addiction and symptoms of social anxiety (Frontiers in Psychology, January 25, 2024)
Energy drink consumption and sleep parameters in college and university students: a national cross-sectional study (BMJ Open, January 24, 2024)
Recurrent cannabis-induced catatonia: a case report and comprehensive systematic literature review (Frontiers in Psychiatry, January 23, 2024)
Reduced drug use as an alternative valid outcome in individuals with stimulant use disorders: Findings from 13 multisite randomized clinical trials (Addiction, January 21, 2024)
Improving the quality of counseling and clinical supervision in opioid treatment programs: how can technology help? (Addiction Science and Clinical Practice, January 20, 2024)
Cannabis Use Among Students in Grades 8, 10, and 12, by Sex — King County, Washington, 2008–2021 (CDC, January 18, 2024)
Systemic Racism as a Determinant of Health Inequities for People With Substance Use Disorder (JAMA Psychiatry, January 18, 2024)
Prenatal Opioid Exposure and Immune-Related Conditions in Children (Free pdf download, JAMA Network Open, January 18, 2024)
Effectiveness of residential treatment services for veterans with substance use disorders: A propensity score matching evaluation (Drug and Alcohol Dependence, January 17, 2024)
Minors and Online Marijuana Accessibility—Navigating the Digital Backdoors—Reply (JAMA Pediatrics, January 16, 2024)
Optimizing methadone dose adjustment in patients with opioid use disorder (Frontiers in Psychiatry, January 16, 2024)
CFSRE Q4 2023 Novel Psychoactive Substances Trends Report (Center for Forensic Science Research Education, January 12, 2023)
CFSRE Novel Psychoactive Substances: 2023 Year in Review (Center for Forensic Science Research Education, January 12, 2023)
Substance use disorder bridge clinics: models, evidence, and future directions (Addiction Science and Clinical Practice, January 11, 2024)
Beyond Trauma-Informed: A Simple Tool to Support Survivors of Intimate Partner Violence (Addiction Technology Transfer System Network, January 9, 2024)
A systematic review and meta-analysis of neuromodulation therapies for substance use disorders (Neuropsychopharmacology, January 9, 2024)
Evaluation of the multimodal DELTA therapy for adolescents with substance use disorders: an exploratory pilot trial (Frontiers in Psychiatry, January 9, 2024)
Benzodiazepine Discontinuation and Mortality Among Patients Receiving Long-Term Benzodiazepine Therapy (Free pdf download. JAMA Network Open, January 8, 2024)
Cannabidiol as a potential cessation therapeutic: Effects on intravenous nicotine self-administration and withdrawal symptoms in mice (Neuropharmacology, January 6, 2024)
Improving the quality of antenatal screening and early intervention for alcohol and other drug use: protocol for a multi-stage approach to systems reform (Addiction Science and Clinical Practice, January 6, 2024)
Hyperthermia, and Myocardial Injury in Three Young Adults Who Consumed Bromazolam Disguised as Alprazolam (CDC, January 5, 2024)
Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report (BMC Psychiatry, January 2, 2024)
Psilocybin Without Psychotherapy: A Cart Without a Horse? (American Journal of Psychiatry, January 1, 2024)
Is Poorly Assisted Psilocybin Treatment an Increasing Risk? (American Journal of Psychiatry, January 1, 2024)
A novel syndrome associated with prenatal fentanyl exposure (Genetics in Medicine, December 29, 2023)
Cannabis use in the United States and its impact on gastrointestinal health (Nutrition in Clinical Practice, December 29, 2023)
Benzodiazepine Use During Pregnancy and Risk of Miscarriage (JAMA Psychiatry, December 27, 2023)
The influence of peer’s social networks on adolescent’s cannabis use: a systematic review of longitudinal studies (Frontiers in Psychiatry, December 27, 2023)
Addiction and the brain: current knowledge, methods, and perspectives (Frontiers in Psychiatry, December 26, 2023)
Predictors of Multiwave Opioid Use Among Older American Adults (Innovations in Aging, December 23, 2023)
Oxycodone, an opioid like the others? (Frontiers in Psychiatry, December 21, 2023)
Craving dynamics and related cerebral substrates predict timing of use in alcohol, tobacco, and cannabis use disorders (Addiction Neuroscience, December 15, 2023)
Editorial: Why we must act quickly and decisively to end the overdose epidemic (American Medical Association, December 15, 2023)
U.S. Senate Hearing on Older Adults and Substance Misuse (December 15, 2023)
Health Risks Associated with Smoking versus Injecting Fentanyl among People Who Use Drugs in California (Drug and Alcohol Dependence, December 15, 2023)
Past-Year Use Prevalence of Cannabidiol, Cannabigerol, Cannabinol, and Δ8-Tetrahydrocannabinol Among US Adults (JAMA Network Open, December 13, 2023)
"Monitoring the Future" detailed graphs for 2022 (University of Michigan, December 13, 2023)
Acute Myocardial Infarction Associated With Amphetamine Use and Smoking in a Young Healthy Individual (Cureus, December 11, 2023)
Effects of brief cognitive behavioral therapy on mental health in substance-related disorder: a randomized controlled trial (BMC Psychiatry, December 8, 2023)
Medetomidine: A new adulterant in street drugs (Fredric Rieders Foundation, December 8, 2023)
Advisory: Low Barrier Models of Care for Substance Use Disorders (SAMHSA, December 8, 2023)
Marijuana use linked with increased risk of heart attack, heart failure (American Heart Association, December 8, 2023)
Psilocybin in Bipolar II Study Provides Preliminary Data on Safety (JAMA Psychiatry, December 6, 2023)
“It feels like I’m coming to a friend’s house”: an interpretive descriptive study of an integrated care site offering injectable opioid agonist treatment (Addiction Science and Clinical Practice, December 3, 2023)
Overdose Prevention Centers, Crime, and Disorder in New York City (Free pdf download, JAMA Open Network, December 1, 2023)
Health status outcome among cannabis addicts after treatment of addiction (PLOS One, November 30, 2023)
Cannabinoid-Associated Hyperemesis Syndrome Treated With Dronabinol: Killing a Poison With the Poison (Cureus, November 30, 2023)
Mobile service delivery in response to the opioid epidemic in Philadelphia (Addiction Science and Clinical Practice, November 30, 2023)
Treatment Episode Data Set (TEDS) 2021: Admissions to and Discharges from Substance Use Treatment Services Reported by Single State Agencies (SAMHSA, January 29, 2023)
Substance misuse programs in commercial aviation (National Academies of Sciences, Engineering and Medicine, January 29, 2023)
Beyond the Bottle: Niacin Deficiency and Chronic Alcoholism (Cureus, November 28, 2023)
Long-Term Cardiovascular Effects of Medications for Attention-Deficit/Hyperactivity Disorder—Balancing Benefits and Risks of Treatment (JAMA Psychiatry, November 25, 2023)
Abrupt Withdrawal From Chronic High-Dose Zolpidem Use: A Case Report of Resulting Delirium (Cureus, November 20, 2023)
Brain Volume in Fetal Alcohol Spectrum Disorders Over a 20-Year Span (Free pdf download, JAMA Open Network, November 17, 2023)
Two subtypes of compulsive sexual behavior disorder (Frontiers in Psychiatry, November 16, 2023)
Lower cortical thickness and increased brain aging in adults with cocaine use disorder (Frontiers in Psychiatry, November 16, 2023)
Results from the 2022 National Survey on Drug Use and Health: A Companion Infographic (SAMHSA, November 15, 2023)
Highlights from the National Survey on Drug Use and Health (SAMHSA, November 15, 2023)
Counseling Approaches To Promote Recovery From Problematic Substance Use and Related Issues Treatment Improvement Protocol (TIP) Series No. 65 (SAMHSA, November 14, 2023)
Marijuana: Forensics of Abuse, Medical Uses, Controversy, and AI (Forensic Sciences, November 11, 2023)
Adoption of Emergency Department–Initiated Buprenorphine for Patients With Opioid Use Disorder (Journal of the American Medical Association, November 11, 2023)
Drug Overdose Mortality Rates by Educational Attainment and Sex for Adults Aged 25–64 in the United States Before and During the COVID-19 Pandemic (Drug and Alcohol Dependence, November 8, 2023)
Alcohol and Skeletal Muscle in Health and Disease (Alcohol Research: Current Reviews, November 8, 2023)
Neural circuit selective for fast but not slow dopamine increases in drug reward (Nature Communications, November 8, 2023)
Stress and addictive disorders (Frontiers in Psychiatry, November 7, 2023)
Fungal and mycotoxin contaminants in cannabis and hemp flowers: implications for consumer health and directions for further research (Frontiers in Microbiology, November 3, 2023)
Factors Associated With Abrupt Discontinuation of Long-Term High-Dose Opioid Treatment (Free pdf download, JAMA Network Open, November 3, 2023)
Strategies to support substance use disorder care transitions from acute-care to community-based settings: a scoping review and typology (Addiction Science and Clinical Practice, November 3, 2023)
Cannabis use disorder, suicide attempts, and self-harm among adolescents (PLOS One, October 31, 2023)
Verbal memory and executive components of recall in adolescent binge drinkers (Frontiers in Psychology, October 31, 2023)
A brain imaging study of dopamine receptor D2 availability in cannabis dependent users after recovery from cannabis-induced psychosis (Frontiers in Psychiatry, October 31, 2023)
Concerns Related to the Consequences of Pediatric Cannabis Use: A 360-Degree View (Children, October 27, 2023)
Xylazine potentiates the lethal but not the rewarding effects of fentanyl in mice (Drug and Alcohol Dependence, October 27, 2023)
Self-reported adverse events associated with ∆8-Tetrahydrocannabinol (Delta-8-THC) Use (Journal of Cannabis Research, October 26, 2023)
Ketamine for depression—Knowns, unknowns, possibilities, barriers, and opportunities (JAMA Psychiatry, Ocotber 26, 2023)
Brodifacoum in Synthetic Cannabinoids (Center for Forensic Research and Education, October 20, 2023)
Patients with cognitive deficits and substance use disorders, a clinical population in need of focused attention (Frontiers in Psychiatry, October 19, 2023)
Age-Adjusted Drug Overdose Death Rates Involving Cocaine by Region (CDC, October 13, 2023)
Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment (Abstract only. JAMA Psychiatry, October 13, 2023)
The temporal association between suicide and comorbid mental disorders in people treated for substance use disorders (Addiction Science and Clinical Practuce, October 12, 2023)
Hippocampal volume loss in individuals with a history of non-fatal opioid overdose (Addiction Biology, October 11, 2023)
Study protocol: implementing and evaluating a trauma-informed model of care in residential youth treatment for substance use disorders (Frontiers in Psychiatry, October 4, 2023)
Cannabis-Involved Traffic Injury Emergency Department Visits After Cannabis Legalization and Commercialization (Free pdf download, JAMA Open Network, October 1, 2023)
Cannabis use disorder and adverse cardiovascular outcomes: A population-based retrospective cohort analysis of adults from Alberta, Canada (Addiction, September 30, 2023)
The association between temperature and alcohol- and substance-related disorder hospital visits in New York State (Communications Medicine, September 28, 2023)
Exploring dog ownership in the lives of people with substance use disorder: a qualitative study (Addiction Science and Clinical Practice, September 28, 2023)
A case of fatal overdose involving both hydromorphone and kratom (Journal of Forensic Sciences, September 27, 2023)
Potential effect of antidepressants on remission from cocaine use disorder (Drug and Alcohol Dependence, September 27, 2023)
Recovery incentives program: California's contingency management benefit (Preventive Medicine, September 27, 2023)
America's Opioid Ecosystem (Free book download, Rand Corporation, September 27, 2023)
Technology-Assisted Buprenorphine Treatment in Rural and Nonrural Settings (Free pdf download, JAMA Open Network, September 27, 2023)
Manic episode following psilocybin use in a man with bipolar II disorder (Frontiers in Psychiatry, September 26, 2023)
Sex difference in alcohol withdrawal syndrome: a scoping review of clinical studies (Frontiers in Psychiatry, September 26, 2023)
Opioid-Overdose Reduction Continuum of Care Approach (ORCCA) Practice Guide 2023 (SAMHSA, September 25, 2023)
Reducing the risk of prenatal alcohol exposure and FASD through social services (Frontiers in Psychiatry, September 21, 2023)
Recovery from Substance Use and Mental Health Problems Among Adults in the United States (SAMHSA, September 20, 2023)
Antidepressant Effects of the Psychedelic Drug Psilocybin (New England Journal of Medicine, September 14, 2023)
How to quit cannabis when you have a mental illness: study from the perspective of patients who have successfully quit (BJPSYCH Bulletin, September 14, 2023)
Validation of Two Diagnostic Assessments for Opioid and Stimulant Use Disorder for Use by Non‐Clinicians (Psychiatric Research abd Clinical Practice, September 12, 2023)
Drug-related ED visits involving suicide attempts (SAMHSA, September 12, 2023)
E-Cigarettes and Stroke Risk (JAMA Neurology, September 12, 2023)
Engaging Community Coalitions to Decrease Opioid Overdose Deaths Practice Guide 2023 (SAMHSA, September 11, 2023)
Cocaine-Induced Four-Extremity Ischemia Caused by a Hypercoagulable State (Cureus, September 8, 2023)
Cannabis and Cannabinoids for Pain and Posttraumatic Stress Disorder in Military Personnel and Veterans (JAMA Psychiatry, September 7, 2023)
Piloting the integration of SMART Recovery into outpatient alcohol and other drug treatment programs (Addiction Science and Clinical Practice, September 7, 2023)
National Governors Association releases Roadmap for Tackling Drug Overdose Epidemic - (National Governors Association, September 2, 2023)
Drug Overdose Deaths with Evidence of Counterfeit Pill Use — United States, July 2019–December 2021 (CDC, August 31, 2023)
Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal (Free pdf download, JAMA Open Network, August 30, 2023)
Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients (Free pdf download, JAMA, August 30, 2023)
Association between cannabis use disorder symptom severity and probability of clinically-documented diagnosis and treatment in a primary care sample (Drug and Alcohol Dependence, August 25, 2023)
Cocaine hydrochloride, cocaine methiodide and methylenedioxypyrovalerone (MDPV) cause distinct alterations in the structure and composition of the gut microbiota (Nature, August 23, 2023)
Management of New Onset Amphetamine-Induced Acute Decompensated Heart Failure in a Young Adult (Cureus, August 22, 2023)
Unintentional Pediatric Ingestion of Cannabis—Addressing a Growing Public Health Risk (JAMA Pediatrics, August 21, 2023)
Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model (Psychological Medicine, August 19, 2023)
A qualitative study of interest in and preferences for potential medications to treat methamphetamine use disorder (Addiction Science and Clinical Practice, August 17, 2023)
Impact of personalized alcohol intake and cognitive feedback on alcohol use behavior in hazardous drinkers: A quasi-randomized trial (Alcohol: Clinical and Experimental Reeaerch, August 16, 2023)
Prevalence and Factors Associated With Vaping Cannabidiol (CBD) Among US Adolescents (Free pdf download. JAMA Open Network, August 16, 2023)
After High School: Talking With Your Young Adult About Underage Drinking (Free pdf download. SAMHSA, August 16, 2023)
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (British Journal of Psychiatry, August 16. 2023)
Connecting Communities to Substance Use Services: Practical Tools for First Responders (Free pdf download, SAMHSA August 15, 2023)
The Future of Addiction Treatment Lies in Narrowing the Treatment Gap (ASAM News, August 15, 2023)
Perceptions of Safety of Daily Cannabis vs Tobacco Smoking and Secondhand Smoke Exposure, 2017-2021 (Download free pdf. JAMA Network Open, August 12, 2023)
Human antibody that targets carfentanil, fentanyl and related opioids reverses overdose effects in preclinical study (Scripps Research, August 12, 2023)
Integrating Opioid Use Disorder Treatment Into Primary Care Settings (JAMA, August 11, 2023)
Guidelines and treatment for illicit drug related presentations in emergency departments: A scoping review (Australian Psychiatry, August 10, 2023)
Fatal Drug Overdose Risks of Health Care Workers in the United States (Annals of Internal Medicine, August 9, 2023)
Monitoring the Future: National Survey Results on Drug Use, 1975-2022: Secondary School Students (University of Michigan, August 4, 2023)
Detection of fentanyl, synthetic opioids, and ketamine in hair specimens from purposive samples of American and Italian populations (Journal of Forensic Sciences, August 4, 2023)
Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar Disorder (JAMA Psychiatry, August 3, 2023)
Extrapharmacological Safety Topics in Psychedelic-Assisted Psychotherapy (JAMA Psychiatry, August 3, 2023)
Psychedelics as Therapeutics—Potential and Challenges (JAMA Psychiatry, August 2, 2023)
Trends in Alcohol-Related Deaths by Sex in the US, 1999-2020 (JAMA Network Open, July 28, 2023)
Purple Haze: issues on cannabis legalization, volume II (Frontiers in Psychiatry, June 28, 2023)
Association of cannabis, cannabidiol and synthetic cannabinoid use with mental health in adolescents (British Journal of Psychiatry, July 26, 2023)
Inhalation heroin use and leukoencephalopathy (Cureus, July 23, 2023)
Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study (Addiction Science and Clinical Practice, July 19, 2023)
Co-involvement of Opioids in Drug Overdose Deaths Involving Cocaine and Psychostimulants, 2011–2021 (CDC, July 19, 2023)
Guidelines for managing substance withdrawal in jails (US Department of Justice, July 18, 2022)
Nucleus accumbens shell neurons’ early sensitivity to cocaine is associated with future increases in drug intake (Addiction Neuroscience, July 17, 2023}
Synthetic Cannabinoids-Related Cardiovascular Emergencies: A Review of the Literature (Cureus, July 16, 2023)
Should Suboxone Be Used to Treat Kratom Addiction?(Cureus, July 10, 2023)
The Double-Edged Sword: Naloxone-Induced Noncardiogenic Pulmonary Edema (Cureus, July 10, 2023)
Psychedelics reopen the social reward learning critical period (Nature, July 4, 2023)
Evaluation of Efficacy of Cannabis Use in Patients with Attention Deficit Hyperactivity Disorder: A Systematic Review (Cureus, July 3, 2023)
E-Cigarette–Associated Cases Reported to Poison Centers — United States, April 1, 2022– March 31, 2023 (CDC, June 30, 2023)
A cross-national comparison of problematic gaming behavior and well-being in adolescents (Journal of Behavioral Addictions, June 30, 2023)
Personality dimensions of compulsive sexual behavior (Journal of Behavioral Addictions, June 30, 2023)
Patients with cognitive deficits and substance use disorders, a clinical population in need of focused attention (Frontiers in Psychiatry, October 19, 2023)
Age-Adjusted Drug Overdose Death Rates Involving Cocaine by Region (CDC, October 13, 2023)
Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment (Abstract only. JAMA Psychiatry, October 13, 2023)
Hippocampal volume loss in individuals with a history of non-fatal opioid overdose (Addiction Biology, October 11, 2023)
Study protocol: implementing and evaluating a trauma-informed model of care in residential youth treatment for substance use disorders (Frontiers in Psychiatry, October 4, 2023)
Cannabis-Involved Traffic Injury Emergency Department Visits After Cannabis Legalization and Commercialization (Free pdf download, JAMA Open Network, October 1, 2023)
Exploring dog ownership in the lives of people with substance use disorder: a qualitative study (Addiction Science and Clinical Practice, September 28, 2023)
Potential effect of antidepressants on remission from cocaine use disorder (Drug and Alcohol Dependence, September 27, 2023)
Recovery incentives program: California's contingency management benefit (Preventive Medicine, September 27, 2023)
Sex difference in alcohol withdrawal syndrome: a scoping review of clinical studies (Frontiers in Psychiatry, September 26, 2023)
Opioid-Overdose Reduction Continuum of Care Approach (ORCCA) Practice Guide 2023 (SAMHSA, September 25, 2023)
Reducing the risk of prenatal alcohol exposure and FASD through social services (Frontiers in Psychiatry, September 21, 2023)
Antidepressant Effects of the Psychedelic Drug Psilocybin (New England Journal of Medicine, September 14, 2023)
How to quit cannabis when you have a mental illness: study from the perspective of patients who have successfully quit (BJPSYCH Bulletin, September 14, 2023)
Validation of Two Diagnostic Assessments for Opioid and Stimulant Use Disorder for Use by Non‐Clinicians (Psychiatric Research abd Clinical Practice, September 12, 2023)
Drug-related ED visits involving suicide attempts (SAMHSA, September 12, 2023)
E-Cigarettes and Stroke Risk (JAMA Neurology, September 12, 2023)
Engaging Community Coalitions to Decrease Opioid Overdose Deaths Practice Guide 2023 (SAMHSA, September 11, 2023)
Cocaine-Induced Four-Extremity Ischemia Caused by a Hypercoagulable State (Cureus, September 8, 2023)
Cannabis and Cannabinoids for Pain and Posttraumatic Stress Disorder in Military Personnel and Veterans (JAMA Psychiatry, September 7, 2023)
Piloting the integration of SMART Recovery into outpatient alcohol and other drug treatment programs (Addiction Science and Clinical Practice, September 7, 2023)
Drug Overdose Deaths with Evidence of Counterfeit Pill Use — United States, July 2019–December 2021 (CDC, August 31, 2023)
Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal (Free pdf download, JAMA Open Network, August 30, 2023)
Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients (Free pdf download, JAMA, August 30, 2023)
Association between cannabis use disorder symptom severity and probability of clinically-documented diagnosis and treatment in a primary care sample (Drug and Alcohol Dependence, August 25, 2023)
Cocaine hydrochloride, cocaine methiodide and methylenedioxypyrovalerone (MDPV) cause distinct alterations in the structure and composition of the gut microbiota (Nature, August 23, 2023)
Management of New Onset Amphetamine-Induced Acute Decompensated Heart Failure in a Young Adult (Cureus, August 22, 2023)
Unintentional Pediatric Ingestion of Cannabis—Addressing a Growing Public Health Risk (JAMA Pediatrics, August 21, 2023)
Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model (Psychological Medicine, August 19, 2023)
A qualitative study of interest in and preferences for potential medications to treat methamphetamine use disorder (Addiction Science and Clinical Practice, August 17, 2023)
Impact of personalized alcohol intake and cognitive feedback on alcohol use behavior in hazardous drinkers: A quasi-randomized trial (Alcohol: Clinical and Experimental Reeaerch, August 16, 2023)
Prevalence and Factors Associated With Vaping Cannabidiol (CBD) Among US Adolescents (Free pdf download. JAMA Open Network, August 16, 2023)
After High School: Talking With Your Young Adult About Underage Drinking (Free pdf download. SAMHSA, August 16, 2023)
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (British Journal of Psychiatry, August 16. 2023)
Connecting Communities to Substance Use Services: Practical Tools for First Responders (Free pdf download, SAMHSA August 15, 2023)
Perceptions of Safety of Daily Cannabis vs Tobacco Smoking and Secondhand Smoke Exposure, 2017-2021 (Download free pdf. JAMA Network Open, August 12, 2023)
Human antibody that targets carfentanil, fentanyl and related opioids reverses overdose effects in preclinical study (Scripps Research, August 12, 2023)
Integrating Opioid Use Disorder Treatment Into Primary Care Settings (JAMA, August 11, 2023)
High-Deductible Health Plans’ Impact on Mental Health and Substance Use Disorder Treatments—Balancing Cost and Care (JAMA Psychiatry, August 10, 2023)
Guidelines and treatment for illicit drug related presentations in emergency departments: A scoping review (Australian Psychiatry, August 10, 2023)
Monitoring the Future: National Survey Results on Drug Use, 1975-2022: Secondary School Students (University of Michigan, August 4, 2023)
Detection of fentanyl, synthetic opioids, and ketamine in hair specimens from purposive samples of American and Italian populations (Journal of Forensic Sciences, August 4, 2023)
Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar Disorder (JAMA Psychiatry, August 3, 2023)
Extrapharmacological Safety Topics in Psychedelic-Assisted Psychotherapy (JAMA Psychiatry, August 3, 2023)
Psychedelics as Therapeutics—Potential and Challenges (JAMA Psychiatry, August 2, 2023)
Trends in Alcohol-Related Deaths by Sex in the US, 1999-2020 (JAMA Network Open, July 28, 2023)
Association of cannabis, cannabidiol and synthetic cannabinoid use with mental health in adolescents (British Journal of Psychiatry, July 26, 2023)
Involvement of the Opioid Peptide Family in Cancer Progression (Biomedicines, July 25, 2023)
Inhalation heroin use and leukoencephalopathy (Cureus, July 23, 2023)
Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study (Addiction Science and Clinical Practice, July 19, 2023)
Co-involvement of Opioids in Drug Overdose Deaths Involving Cocaine and Psychostimulants, 2011–2021 (CDC, July 19, 2023)
Multi-animal-model study reveals mutations in neural plasticity and nociception genes linked to excessive alcohol drinking (Alcohol: Clinical and Experimental Research, July 18, 2023)
Nucleus accumbens shell neurons’ early sensitivity to cocaine is associated with future increases in drug intake (Addiction Neuroscience, July 17, 2023}
Synthetic Cannabinoids-Related Cardiovascular Emergencies: A Review of the Literature (Cureus, July 16, 2023)
Should Suboxone Be Used to Treat Kratom Addiction?(Cureus, July 10, 2023)
The Double-Edged Sword: Naloxone-Induced Noncardiogenic Pulmonary Edema (Cureus, July 10, 2023)
Psychedelics reopen the social reward learning critical period (Nature, July 4, 2023)
Evaluation of Efficacy of Cannabis Use in Patients with Attention Deficit Hyperactivity Disorder: A Systematic Review (Cureus, July 3, 2023)
E-Cigarette–Associated Cases Reported to Poison Centers — United States, April 1, 2022– March 31, 2023 (CDC, June 30, 2023)
Personality dimensions of compulsive sexual behavior (Journal of Behavioral Addictions, June 30, 2023)
Patients with cognitive deficits and substance use disorders, a clinical population in need of focused attention (Frontiers in Psychiatry, October 19, 2023)
EU Drug Market: Amphetamine — Key findings and threat assessment (European Centre for Drugs and Drug Monitoring, October 16, 2023)
Age-Adjusted Drug Overdose Death Rates Involving Cocaine by Region (CDC, October 13, 2023)
Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment (Abstract only. JAMA Psychiatry, October 13, 2023)
The temporal association between suicide and comorbid mental disorders in people treated for substance use disorders (Addiction Scuence and Clinical Practuce, October 12, 2023)
Hippocampal volume loss in individuals with a history of non-fatal opioid overdose (Addiction Biology, October 11, 2023)
Study protocol: implementing and evaluating a trauma-informed model of care in residential youth treatment for substance use disorders (Frontiers in Psychiatry, October 4, 2023)
Cannabis-Involved Traffic Injury Emergency Department Visits After Cannabis Legalization and Commercialization (Free pdf download, JAMA Open Network, October 1, 2023)
Cannabis use disorder and adverse cardiovascular outcomes: A population-based retrospective cohort analysis of adults from Alberta, Canada (Addiction, September 30, 2023)
Exploring dog ownership in the lives of people with substance use disorder: a qualitative study (Addiction Science and Clinical Practice, September 28, 2023)
A case of fatal overdose involving both hydromorphone and kratom (Journal of Forensic Sciences, September 27, 2023)
Potential effect of antidepressants on remission from cocaine use disorder (Drug and Alcohol Dependence, September 27, 2023)
Recovery incentives program: California's contingency management benefit (Preventive Medicine, September 27, 2023)
America's Opioid Ecosystem (Free book download, Rand Corporation, September 27, 2023)
Technology-Assisted Buprenorphine Treatment in Rural and Nonrural Settings (Free pdf download, JAMA Open Network, September 27, 2023)
Sex difference in alcohol withdrawal syndrome: a scoping review of clinical studies (Frontiers in Psychiatry, September 26, 2023)
Opioid-Overdose Reduction Continuum of Care Approach (ORCCA) Practice Guide 2023 (SAMHSA, September 25, 2023)
Reducing the risk of prenatal alcohol exposure and FASD through social services (Frontiers in Psychiatry, September 21, 2023)
Recovery from Substance Use and Mental Health Problems Among Adults in the United States (SAMHSA, September 20, 2023)
Antidepressant Effects of the Psychedelic Drug Psilocybin (New England Journal of Medicine, September 14, 2023)
How to quit cannabis when you have a mental illness: study from the perspective of patients who have successfully quit (BJPSYCH Bulletin, September 14, 2023)
Validation of Two Diagnostic Assessments for Opioid and Stimulant Use Disorder for Use by Non‐Clinicians (Psychiatric Research abd Clinical Practice, September 12, 2023)
E-Cigarettes and Stroke Risk (JAMA Neurology, September 12, 2023)
Cocaine-Induced Four-Extremity Ischemia Caused by a Hypercoagulable State (Cureus, September 8, 2023)
Cannabis and Cannabinoids for Pain and Posttraumatic Stress Disorder in Military Personnel and Veterans (JAMA Psychiatry, September 7, 2023)
Drug Overdose Deaths with Evidence of Counterfeit Pill Use — United States, July 2019–December 2021 (CDC, August 31, 2023)
Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal (Free pdf download, JAMA Open Network, August 30, 2023)
Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients (Free pdf download, JAMA, August 30, 2023)
Association between cannabis use disorder symptom severity and probability of clinically-documented diagnosis and treatment in a primary care sample (Drug and Alcohol Dependence, August 25, 2023)
Cocaine and amphetamine regulated transcript (CART) mediates sex differences in binge drinking through central taste circuits (Neuropsychopharmacology, August 23, 2023)
Management of New Onset Amphetamine-Induced Acute Decompensated Heart Failure in a Young Adult (Cureus, August 22, 2023)
Unintentional Pediatric Ingestion of Cannabis—Addressing a Growing Public Health Risk (JAMA Pediatrics, August 21, 2023)
Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model (Psychological Medicine, August 19, 2023)
A qualitative study of interest in and preferences for potential medications to treat methamphetamine use disorder (Addiction Science and Clinical Practice, August 17, 2023)
Prevalence and Factors Associated With Vaping Cannabidiol (CBD) Among US Adolescents (Free pdf download. JAMA Open Network, August 16, 2023)
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (British Journal of Psychiatry, August 16. 2023)
Connecting Communities to Substance Use Services: Practical Tools for First Responders (Free pdf download, SAMHSA August 15, 2023)
The Future of Addiction Treatment Lies in Narrowing the Treatment Gap (ASAM News, August 15, 2023)
Integrating Opioid Use Disorder Treatment Into Primary Care Settings (JAMA, August 11, 2023)
Guidelines and treatment for illicit drug related presentations in emergency departments: A scoping review (Australian Psychiatry, August 10, 2023)
Fatal Drug Overdose Risks of Health Care Workers in the United States (Annals of Internal Medicine, August 9, 2023)
Monitoring the Future: National Survey Results on Drug Use, 1975-2022: Secondary School Students (University of Michigan, August 4, 2023)
Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar Disorder (JAMA Psychiatry, August 3, 2023)
Extrapharmacological Safety Topics in Psychedelic-Assisted Psychotherapy (JAMA Psychiatry, August 3, 2023)
Psychedelics as Therapeutics—Potential and Challenges (JAMA Psychiatry, August 2, 2023)
Purple Haze: issues on cannabis legalization, volume II (Frontiers in Psychiatry, June 28, 2023)
Association of cannabis, cannabidiol and synthetic cannabinoid use with mental health in adolescents (British Journal of Psychiatry, July 26, 2023)
Inhalation heroin use and leukoencephalopathy (Cureus, July 23, 2023)
Co-involvement of Opioids in Drug Overdose Deaths Involving Cocaine and Psychostimulants, 2011–2021 (CDC, July 19, 2023)
Nucleus accumbens shell neurons’ early sensitivity to cocaine is associated with future increases in drug intake (Addiction Neuroscience, July 17, 2023}
Synthetic Cannabinoids-Related Cardiovascular Emergencies: A Review of the Literature (Cureus, July 16, 2023)
Psychedelics reopen the social reward learning critical period (Nature, July 4, 2023)
Evaluation of Efficacy of Cannabis Use in Patients with Attention Deficit Hyperactivity Disorder: A Systematic Review (Cureus, July 3, 2023)
E-Cigarette–Associated Cases Reported to Poison Centers — United States, April 1, 2022– March 31, 2023 (CDC, June 30, 2023)
Copyright © 2024, JRW Behavioral Health Services. All Rights Reserved.
Powered by GoDaddy